具体细节公布！香港交易所与香港证监会正式推出“科企专线”

智通财经2025-05-06

智通财经APP获悉，5月6日，香港证监会与香港交易所今天发出联合公告，宣布正式推出"科企专线"，以进一步便利特专科技公司及生物科技公司申请上市，并允许这些公司可以选择以保密形式提交上市申请。此外，联交所已经更新《新上市申请人指南》(《指南》)，以说明这两类公司在采用不同投票权架构上市时，将被联交所视为已满足《主板上市规则》第八A章所列的创新产业公司规定及外界认可规定。具体细节如下："科企专线"透过...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2533577771?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-06 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533577771","market":"us","top_or_hot":-1,"title":"具体细节公布！香港交易所与香港证监会正式推出“科企专线”","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，5月6日，香港证监会与香港交易所今天发出联合公告，宣布正式推出\"科企专线\"，以进一步便利特专科技公司及生物科技公司申请上市，并允许这些公司可以选择以保密形式提交上市申请。此外，联交所已经更新《新上市申请人指南》(《指南》)，以说明这两类公司在采用不同投票权架构上市时，将被联交所视为已满足《主板上市规则》第八A章所列的创新产业公司规定及外界认可规定。具体细节如下：\"科企专线\"透过...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1289613.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>具体细节公布！香港交易所与香港证监会正式推出“科企专线”</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n具体细节公布！香港交易所与香港证监会正式推出“科企专线”\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-06 17:03 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1289613.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，5月6日，香港证监会与香港交易所今天发出联合公告，宣布正式推出\"科企专线\"，以进一步便利特专科技公司及生物科技公司申请上市，并允许这些公司可以选择以保密形式提交上市申请。此外，联交所已经更新《新上市申请人指南》(《指南》)，以说明这两类公司在采用不同投票权架构上市时，将被联交所视为已满足《主板上市规则》第八A章所列的创新产业公司规定及外界认可规定。具体细节如下：\"科企专线\"透过...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1289613.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0630378692.HKD","symbol_name":"HSBC GIF ASIA PACIFIC EX JAPAN EQ HD \"AM2\" (HKD) INC","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1289613.html","article_id":"2533577771","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533577771","pubTimestamp":1746522235,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，5月6日，香港证监会与香港交易所今天发出联合公告，宣布正式推出\"科企专线\"，以进一步便利特专科技公司及生物科技公司申请上市，并允许这些公司可以选择以保密形式提交上市申请。香港证监会企业融资部执行董事戴霖先生表示：\"证监会支持设立“科企专线”及允许特专科技公司和生物科技公司可以选择以保密形式提交上市申请，以巩固香港作为新兴及创新公司首选上市平台的地位。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"80388":"香港交易所-R","LU0630378692.HKD":"HSBC GIF ASIA PACIFIC EX JAPAN EQ HD \"AM2\" (HKD) INC","IE00B3T34201.USD":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","LU0348814723.USD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"A\" (USD) INC  NC","LU0762540952.USD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED INCOME \"AC\" (USD) ACC","LU0165289439.USD":"HSBC GIF ASIA EX JAPAN EQUITY \"AC\" ACC","LU0516422440.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"A\" (USD) ACC","00388":"香港交易所","LU1282648689.USD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AMG\" (USD) INC","LU0197773673.USD":"HSBC GIF ASIA PACIF EX JAPAN EQ HD \"AS\" (USD) INC","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD","LU0607220059.USD":"SCHRODER ISF HONG KONG EQUITY \"A\" (USD) ACC","SG9999001846.SGD":"Schroder Asian Equity Yield A Dis SGD","LU0516422952.EUR":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (EUR) ACC","IE00BZ08YR35.GBP":"GUINNESS BEST OF CHINA \"C\" (GBP) ACC","LU0043850808.USD":"HSBC GIF ASIA EX JAPAN EQUITY \"AD\" INC","LU0067412154.USD":"UBS (LUX) EQUITY FUND -  CHINA OPPORTUNITY \"P\" (USD) ACC","LU1328277881.USD":"MANULIFE GF DRAGON GROWTH FUND \"AA\" (USD) INC","LU0501845795.SGD":"瑞银大中华区股票基金P Acc SGD","LU0577902538.SGD":"Fullerton Lux Funds - Asia Growth and Income Equities A Acc SGD","HKXCY":"香港交易所ADR","LU0417516738.SGD":"Allianz Hong Kong Equity AT Acc SGD","LU0577902611.USD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"A\" (USD) ACC","LU1242518931.SGD":"Fullerton Lux Funds - Asia Absolute Alpha A Acc SGD","LU2226246903.HKD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AT4\" (HKD) ACC","LU0577902454.USD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (USD) ACC","LU1366334651.USD":"ALLSPRING EMERGING MARKETS EQUITY INCOME \"I\" (USD) INC","LU0577902371.SGD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (SGD) ACC","LU1282649141.HKD":"ALLIANZ ASIAN MULTI INCOME PLUS \"AMG\" (HKD) INC","LU0314109678.HKD":"MANULIFE GF DRAGON GROWTH \"AA\" (HKD) INC","LU0886674414.USD":"CT (LUX) I ASIAN EQUITY INCOME \"AUP\" (USD) INC","LU0594300419.USD":"富达中国消费基金A","LU0516422366.SGD":"Fullerton Lux Funds - Asia Focus Equities A Acc SGD","LU0384037296.USD":"ALLIANZ ASIAN MULTI INCOME PLUS \"AT\" (USD) ACC","SG9999002463.SGD":"LionGlobal China Growth SGD","LU1044876610.USD":"THREADNEEDLE (LUX) ASIAN CONTRARIAN EQUITY \"ZU\" (USD) ACC","LU0096374516.USD":"CT (LUX) I ASIA EQUITY INCOME \"DU\" (USD) ACC","LU0605514214.HKD":"FIDELITY CHINA CONSUMER \"A\" (HKD) ACC","LU0898667661.SGD":"JPMorgan Funds - Asia Pacific Income A (mth) SGD-H","LU1481107354.HKD":"HSBC GIF HONG KONG EQUITY \"AD\" (HKD) INC","LU1366334578.USD":"ALLSPRING EMERGING MARKETS EQUITY INCOME \"A\" (USD) INC","LU0061477393.USD":"CT (LUX) I ASIA EQUITY INCOME \"AU\" (USD) ACC","LU1642822792.SGD":"THREADNEEDLE (LUX) ASIAN CONTRARIAN EQUITY \"A\" (SGD) ACC","LU2257852520.SGD":"JPMorgan Funds - Asia Growth A (acc) SGD","LU0516423091.SGD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (SGD) ACC","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","LU1105468828.SGD":"Allianz Total Return Asian Equity AM DIS H2-SGD","LU0791591158.USD":"ALLSPRING  EMERGING MARKTES EQUITY INCOME \"I\" (USD) ACC","LU0918141887.USD":"安联亚洲实际收益股票基金","IE00BKZH1Z71.USD":"BNY MELLON ASIAN INCOME \"B\" (USD) ACC"},"translate_title":"Specific details announced! The Hong Kong Stock Exchange and the Hong Kong Securities Regulatory Commission officially launched the \"Science and Technology Enterprise Hotline\"","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"80388":0.6,"HKXCY":0.6,"00388":1},"content_text":"智通财经APP获悉，5月6日，香港证监会与香港交易所今天发出联合公告，宣布正式推出\"科企专线\"，以进一步便利特专科技公司及生物科技公司申请上市，并允许这些公司可以选择以保密形式提交上市申请。此外，联交所已经更新《新上市申请人指南》(《指南》)，以说明这两类公司在采用不同投票权架构上市时，将被联交所视为已满足《主板上市规则》第八A章所列的创新产业公司规定及外界认可规定。具体细节如下：\"科企专线\"透过联交所提供的以下措施，“科企专线”旨在帮助有意来港上市的特专科技公司及生物科技公司在提交正式的上市申请之前理解适用的《上市规则》及进行相关的上市筹备工作：由具备相关经验(即审批《主板上市规则》第十八C章及十八A章上市申请及为之提供指引)的专业团队领衔;接触潜在申请人，更深入了解其公司业务并帮助其理解《上市规则》的要求;就上市资格及合适性提供指引，例如核心产品要求、是否接受其他生物科技产品及/或不同药监机构监管的临床试验、资深投资者的资格及独立性、特专科技行业可接纳领域，以及接纳当前范围以外的其他新领域/行业为特专科技行业的考虑因素;及这类申请人可就与《上市规则》有关的具体问题与联交所探讨并寻求初步指引。以保密形式提交申请特专科技公司及生物科技公司一般处于早期发展阶段或产品尚未商业化的阶段。与其他行业相比，过早或长期披露公司的营运策略、专有技术或上市计划，可能会为这些公司带来过高的风险。为帮助这些公司减轻有关风险，联交所将允许根据《主板上市规则》第十八C章及十八A章上市的公司4以保密形式提交申请版本。有关进一步详情，请参阅《指南》第6.4章。自本公告之日后，特专科技公司及生物科技公司可以选择以保密形式提交上市申请。寻求以不同投票权架构上市的，特专科技公司及生物科技公司《主板上市规则》第八A章、十八C章及十八A章均是专为有类似需要的新兴及创新领域申请人而设的上市机制，这些上市章节对于寻求上市的申请人均有关于首次公开招股前第三方投资的类似规定。完全符合《主板上市规则》第十八C章的特专科技公司及完全符合《主板上市规则》第十八A章的生物科技公司，将被视为已满足《主板上市规则》第八A章所列的创新产业公司规定和外界认可规定，即符合有不同投票权架构的公司上市应满足的创新产业公司资格。有关进一步详情，请参阅《指南》第2.2、2.3及2.5章。香港交易所上市主管伍洁旋表示，香港交易所致力吸引世界各地的优质公司来港上市，并对潜在发行人筹备上市的过程提供支持。因此，很高兴推出“科企专线”，为特专科技公司及生物科技公司在提交上市申请前提供专门的指引。“科企专线”在这些企业筹备上市的早期阶段为它们解答关键问题，帮助它们更清楚地了解并满足相关上市规定，进一步协助它们更有效率地筹备上市。通过“科企专线”，香港交易所希望不断提升监管透明度，支持创新企业的发展，推动科技进步，进一步增强香港市场的活力、竞争力和韧性。香港证监会企业融资部执行董事戴霖先生表示：\"证监会支持设立“科企专线”及允许特专科技公司和生物科技公司可以选择以保密形式提交上市申请，以巩固香港作为新兴及创新公司首选上市平台的地位。是次举措再次展示了证监会致力于促进发展一个充满活力、多元和高品质的上市市场，同时确保上市制度能够适应全球市场的变化，并足够稳健地保护投资者。\"","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2533577771","isCrawlerRequest":true}